A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute
  • Astellas Pharma US

This publication has 43 references indexed in Scilit: